Header cover image

Spanish Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Oryzon Genomics

Market Cap: €241.7m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.

ORY

€3.07

7D

-6.6%

1Y

84.9%